SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950149-99-000975
Filing Date
1999-05-17
Accepted
1999-05-17 00:00:00
Documents
12
Period of Report
1999-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT FOR PERIOD ENDED 3/31/99 10-Q 54927
2 EMPLOYMENT AGREEMENT EX-10.97 31013
3 SERIES A PREFERRED STOCK PURCHASE AGREEMENT EX-10.98 83998
4 THIRD AMENDMENT TO EXPANSION LEASE EX-10.99 11200
5 FOURTH AMENDMENT TO EXPANSION LEASE EX-10.100 8886
6 FIRST AMENDMENT TO THE RESEARCH AGREEMENT EX-10.101 4155
7 SEVENTH AMENDMENT TO THE LEASE AGREEMENT EX-10.102 4412
8 EIGHTH AMENDMENT TO THE LEASE AGREEMENT EX-10.103 10036
9 NINTH AMENDMENT TO THE LEASE AGREEMENT EX-10.104 5072
10 TERMINANTION OF COLLABORATIVE RESEARCH AGREEMENT EX-10.105 13480
11 TERMINATION AGREEMENT EX-10.106 10514
12 FINANCIAL DATA SCHEDULE EX-27 2416
  Complete submission text file 0000950149-99-000975.txt   242914
Mailing Address 180 KIMBALL WAY SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SOUTH SAN FRANCISCO CA 94080 6508291000
AXYS PHARMECUETICALS INC (Filer) CIK: 0000913056 (see all company filings)

IRS No.: 222969941 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22788 | Film No.: 99625906
SIC: 2834 Pharmaceutical Preparations